Actively Recruiting
Psychoeducational Course for Suicide Prevention
Led by St. Olavs Hospital · Updated on 2025-02-26
80
Participants Needed
2
Research Sites
395 weeks
Total Duration
On this page
Sponsors
S
St. Olavs Hospital
Lead Sponsor
H
Helse Nord-Trøndelag HF
Collaborating Sponsor
AI-Summary
What this Trial Is About
The plan is to include patients with a history of increased risk of suicide. In the aftermath of an episode of imminent suicide risk, patients will receive a psychoeducational course that entails information on different aspects of suicide-related topics, identifying triggers and detecting early warning signals for increased suicide risk. The course culminates in working on completing a individual safety plan to prevent an future increase in suicide risk. The course will incorporate both patients and their next of kin. The psychoeducational course will be compared to a control group where the patients receive one individual session with focus on a safety plan to evaluate the intervention. Both groups will receive treatment as usual (TAU) during both the acute phase and follow-up. The study will be conducted as a randomized controlled trial.
CONDITIONS
Official Title
Psychoeducational Course for Suicide Prevention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a suicide attempt, suicidal behavior, or risk of suicidal behavior and a clinician evaluating that the patient has an intention to die
- Patients with a suicide attempt or suicidal behavior defined as a self-inflicted, potentially injurious behavior with a non-fatal outcome and evidence of intention of death or close to a suicidal crisis syndrome
- Age between 18 and 99 years
You will not qualify if you...
- Not fluent enough in Norwegian to provide informed consent, valid responses, or benefit from the course
- Known diagnosis of ICD-10 F 60.3 (borderline personality disorder) with similar symptoms at previous admissions
- Ongoing psychosis
- Substance abuse preventing compliance with protocol or posing risk during courses
- Organic brain disorders or mental disabilities preventing compliance with protocol
- Unable to give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Helse Nord-Trøndelag
Levanger, Trøndelag, Norway, 7600
Actively Recruiting
2
St. Olav Hospital
Trondheim, Trøndelag, Norway, 7006
Actively Recruiting
Research Team
K
Katrine K Fjukstad, PhD
CONTACT
T
Thine Rishaug, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here